PT Medikaloka Hermina Tbk (HEAL.JK)
IDR 1420.0
(-1.73%)
IDR 1420.0
(-1.73%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5784.08 Billion | 4901.81 Billion | 5820.12 Billion | 4416.04 Billion | 3630.94 Billion | 3058.09 Billion |
| Cost of Revenue | 3959.84 Billion | 3193.42 Billion | 2924.63 Billion | 2281.49 Billion | 2004.68 Billion | 1704.48 Billion |
| Gross Profit | 1824.23 Billion | 1708.38 Billion | 2895.49 Billion | 2134.54 Billion | 1626.25 Billion | 1353.6 Billion |
| Operating Expenses | 1043.54 Billion | 1192.03 Billion | 1257.95 Billion | 1164.34 Billion | 1074.06 Billion | 990.03 Billion |
| Selling, General and Administrative Expenses | 907.17 Billion | 229.03 Billion | 221.35 Billion | 258.25 Billion | 187.92 Billion | 168.69 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 962.99 Billion | 1036.6 Billion | 906.09 Billion | 886.14 Billion | 26.79 Billion |
| Cost and Expenses | 5003.38 Billion | 4385.45 Billion | 4182.59 Billion | 3445.84 Billion | 3078.75 Billion | 2694.51 Billion |
| Operating Income | 780.69 Billion | 587.37 Billion | 1778.16 Billion | 1041.93 Billion | 583.33 Billion | 385.97 Billion |
| Interest Expense | 139.56 Billion | 139.83 Billion | 143.19 Billion | 128.8 Billion | 108.87 Billion | 130.68 Billion |
| Income Tax Expense | 151.1 Billion | 101.31 Billion | 358.42 Billion | 300.37 Billion | 161.55 Billion | 84.51 Billion |
| Earnings before Tax | 710.39 Billion | 480.08 Billion | 1658.2 Billion | 946.01 Billion | 505.47 Billion | 275.53 Billion |
| Net Income | 437.34 Billion | 298.59 Billion | 995.97 Billion | 645.63 Billion | 343.92 Billion | 124.37 Billion |
| Earnings Per Share Basic | 30.16 | 20.64 | 67.73 | 43.54 | 23.14 | 8.86 |
| Earnings Per Share Diluted | 29.73 | 20.57 | 66.80 | 43.37 | 22.79 | 8.86 |
| Weighted Average Shares Outstanding | 14.5 Billion | 14.46 Billion | 14.7 Billion | 14.82 Billion | 14.86 Billion | 14.03 Billion |
| Weighted Average Shares Outstanding (Diluted) | 14.71 Billion | 14.51 Billion | 14.9 Billion | 14.88 Billion | 15.08 Billion | 14.03 Billion |
| Gross Margin | 0.32 | 0.35 | 0.50 | 0.48 | 0.45 | 0.44 |
| EBIT Margin | 0.27 | 0.15 | 0.33 | 0.26 | 0.19 | 0.17 |
| Profit Margin | 0.08 | 0.06 | 0.17 | 0.15 | 0.09 | 0.04 |
| EBITDA | 1584.42 Billion | 1174.25 Billion | 2224.95 Billion | 1369.73 Billion | 810.87 Billion | 593.69 Billion |
| Earnings Before Tax Margin | 0.13 | 0.12 | 0.31 | 0.24 | 0.16 | 0.13 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1682.27 Billion | 1637.84 Billion | 1706.41 Billion | 5784.08 Billion | 1554.21 Billion | 1538.42 Billion |
| Cost of Revenue | 1088.43 Billion | 1103.42 Billion | 1075.64 Billion | 3959.84 Billion | 1103.8 Billion | 955.05 Billion |
| Gross Profit | 593.83 Billion | 534.42 Billion | 630.76 Billion | 1824.23 Billion | 450.4 Billion | 583.37 Billion |
| Operating Expenses | 354.24 Billion | 253.81 Billion | 299.61 Billion | 1043.54 Billion | 286.64 Billion | 322.22 Billion |
| Selling, General and Administrative Expenses | 45.69 Billion | 253.81 Billion | 299.61 Billion | - | 286.64 Billion | 38.02 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 308.55 Billion | 2.35 Billion | 2.17 Billion | 36.77 Billion | 14.51 Billion | 9.1 Billion |
| Cost and Expenses | 1442.68 Billion | 1357.23 Billion | 1375.25 Billion | 5003.38 Billion | 1390.45 Billion | 1277.28 Billion |
| Operating Income | 250.12 Billion | 280.6 Billion | 331.15 Billion | 780.69 Billion | 163.75 Billion | 270.3 Billion |
| Interest Expense | 49.09 Billion | 36.94 Billion | 38.44 Billion | 139.56 Billion | 37.67 Billion | 35.98 Billion |
| Income Tax Expense | 52.65 Billion | 53.21 Billion | 61.14 Billion | 151.1 Billion | 32.37 Billion | 55.44 Billion |
| Earnings before Tax | 208.14 Billion | 251.17 Billion | 305.04 Billion | 710.39 Billion | 150.15 Billion | 242.85 Billion |
| Net Income | 125 Billion | 152.21 Billion | 190.94 Billion | 437.34 Billion | 88.5 Billion | 146.49 Billion |
| Earnings Per Share Basic | 8.38 | 10.23 | 12.96 | - | 6.08 | 10.11 |
| Earnings Per Share Diluted | 8.38 | 10.23 | 12.92 | - | 5.73 | 10.07 |
| Weighted Average Shares Outstanding | 14.91 Billion | 14.87 Billion | 14.72 Billion | 14.5 Billion | 14.54 Billion | 14.49 Billion |
| Weighted Average Shares Outstanding (Diluted) | 14.91 Billion | 14.87 Billion | 14.78 Billion | 14.71 Billion | 15.43 Billion | 14.54 Billion |
| Gross Margin | 0.35 | 0.33 | 0.37 | 0.32 | 0.29 | 0.38 |
| EBIT Margin | 0.19 | 0.29 | 0.28 | - | 0.25 | 0.22 |
| Profit Margin | 0.07 | 0.09 | 0.11 | 0.08 | 0.06 | 0.10 |
| EBITDA | 326.43 Billion | 483.15 Billion | 483.13 Billion | - | 392.94 Billion | 342.38 Billion |
| Earnings Before Tax Margin | 0.15 | 0.17 | 0.19 | 0.13 | 0.11 | 0.18 |
WFHG
NATURAL
2453
BALD-B
IMUC
PSHG